Abstract
Xinyi Fang, Jiahua Wei
Abstract
Authors
Institutions
Provenance
crossref
Confidence 100%
ror
Confidence 99%
No local reference links have been materialized yet.
10.1038/nrendo.2017.151
10.1038/nrendo.2017.151
The Relationship Between Obesity, Overweight, and the Human Development Index in World Health Organization Eastern Mediterranean Region Countries
10.3961/jpmph.19.100 · 2020
Repositioning of the global epicentre of non-optimal cholesterol
10.1038/s41586-020-2338-1 · 2020
10.1016/j.amjmed.2013.02.035
10.1016/j.amjmed.2013.02.035
The Intervention Effect of Traditional Chinese Medicine on the Intestinal Flora and Its Metabolites in Glycolipid Metabolic Disorders
2019
The combination of cinnamaldehyde and kaempferol ameliorates glucose and lipid metabolism disorders by enhancing lipid metabolism via AMPK activation
10.1016/j.jff.2021.104556 · 2021
Synergistic Effect of Omega-3 Fatty Acids and Oral-Hypoglycemic Drug on Lipid Normalization through Modulation of Hepatic Gene Expression in High Fat Diet with Low Streptozotocin-Induced Diabetic Rats
10.3390/nu12123652 · 2020
Synergistic activation of thermogenic adipocytes by a combination of PPARγ activation, SMAD3 inhibition and adrenergic receptor activation ameliorates metabolic abnormalities in rodents
10.1007/s00125-019-4938-6 · 2019
The effects of hypoxia on hunger perceptions, appetite-related hormone concentrations and energy intake: A systematic review and meta-analysis
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
openalex
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
10.1016/j.appet.2018.01.015 · 2018
Corrigendum to “Deficiency of leptin receptor in myeloid cells disrupts hypothalamic metabolic circuits and causes body weight increase” [Molecular Metabolism 7 (2018) 155–160]
10.1016/j.molmet.2018.12.006 · 2019
10.2337/db11-0785
10.2337/db11-0785
10.1016/j.cmet.2013.12.015
10.1016/j.cmet.2013.12.015
10.1016/j.cmet.2015.04.008
10.1016/j.cmet.2015.04.008
10.1016/j.metabol.2021.154892
10.1016/j.metabol.2021.154892
10.1038/s41580-021-00390-6
10.1038/s41580-021-00390-6
10.1038/s41586-019-1797-8
10.1038/s41586-019-1797-8
10.1016/j.redox.2021.101887
10.1016/j.redox.2021.101887
10.1038/nrendo.2015.189
10.1038/nrendo.2015.189
10.1016/j.celrep.2021.109161
10.1016/j.celrep.2021.109161
10.1007/s13238-020-00814-7
10.1007/s13238-020-00814-7
10.3390/microorganisms8040527
10.3390/microorganisms8040527
10.1016/j.arr.2021.101346
10.1016/j.arr.2021.101346
10.1038/s41576-020-0216-1
10.1038/s41576-020-0216-1
10.1038/nature19806
10.1038/nature19806
Unresolved referenced work
Kept as external metadata until matched
Correction: Transcription factor-7-like 2 (TCF7L2) gene acts downstream of the Lkb1/Stk11 kinase to control mTOR signaling, β cell growth, and insulin secretion
10.1074/jbc.aac118.006541 · 2018
10.1038/ng1732
10.1038/ng1732
Meta-analysis of association between TCF7L2 polymorphism rs7903146 and type 2 diabetes mellitus
10.1186/s12881-018-0553-5 · 2018
10.1016/j.numecd.2017.10.012
10.1016/j.numecd.2017.10.012
A common rs7903146 variant of the transcription factor 7-like 2 gene is associated with type 2 diabetes mellitus and fasting glucose in a Taiwanese population
10.1016/j.diabet.2016.05.003 · 2017
Impact of KCNQ1, CDKN2A/2B, CDKAL1, HHEX, MTNR1B, SLC30A8, TCF7L2, and UBE2E2 on risk of developing type 2 diabetes in Thai population
10.1186/s12881-018-0614-9 · 2018
Human peroxisome proliferator-activated receptor-gamma2: genetic mapping, identification of a variant in the coding sequence, and exclusion as the gene responsible for lipoatrophic diabetes
10.2337/diabetes.47.3.490 · 1998
10.3390/ijms19072124
10.3390/ijms19072124
10.1038/nature05616
10.1038/nature05616
10.1126/science.1142382
10.1126/science.1142382
10.2337/db08-0047
10.2337/db08-0047
10.2337/db08-0877
10.2337/db08-0877
10.1126/science.1151710
10.1126/science.1151710
Influence of FTO rs9939609 polymorphism on appetite, ghrelin, leptin, IL6, TNFα levels, and food intake of women with morbid obesity
10.2147/dmso.s154978 · 2018
10.1371/journal.pone.0165523
10.1371/journal.pone.0165523
Probiotic yogurt improves antioxidant status in type 2 diabetic patients
10.1016/j.nut.2011.08.013 · doi-reference
10.1111/jdi.12673
10.1111/jdi.12673 · doi-reference
Brain-gut-microbe communication in health and disease
10.3389/fphys.2011.00094 · doi-reference
10.1038/nrd.2016.32
10.1038/nrd.2016.32 · doi-reference
10.1038/s41591-019-0414-6
10.1038/s41591-019-0414-6 · doi-reference
10.1038/s41586-019-1236-x
10.1038/s41586-019-1236-x · doi-reference
Decreased Abundance of Akkermansia muciniphila Leads to the Impairment of Insulin Secretion and Glucose Homeostasis in Lean Type 2 Diabetes
10.1002/advs.202100536 · doi-reference
Small intestine proteomics coupled with serum metabolomics reveal disruption of amino acid metabolism in Chinese hamsters with type 2 diabetes mellitus
10.1016/j.jprot.2020.103823 · doi-reference
10.1038/s41586-020-2928-y
10.1038/s41586-020-2928-y · doi-reference
Integrative genomics reveal a role for MCPIP1 in adipogenesis and adipocyte metabolism
10.1007/s00018-019-03434-5 · doi-reference
Diabetes causes marked inhibition of mitochondrial metabolism in pancreatic β-cells
10.1038/s41467-019-10189-x · doi-reference
10.1016/j.chom.2019.07.004
10.1016/j.chom.2019.07.004 · doi-reference
10.1038/nm.4358
10.1038/nm.4358 · doi-reference
10.1038/nature05414
10.1038/nature05414 · doi-reference
10.1038/nature15766
10.1038/nature15766 · doi-reference
10.1136/gutjnl-2014-308778
10.1136/gutjnl-2014-308778 · doi-reference
Comparison of the gut microbiota composition between obese and non-obese individuals in a Japanese population, as analyzed by terminal restriction fragment length polymorphism and next-generation sequencing
10.1186/s12876-015-0330-2 · doi-reference
10.1016/j.diabet.2016.04.004
10.1016/j.diabet.2016.04.004 · doi-reference
10.1038/nature12198
10.1038/nature12198 · doi-reference
Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters
10.1038/tpj.2012.43 · doi-reference
Characteristics of gut microbiota and its response to a Chinese Herbal Formula in elder patients with metabolic syndrome
10.5582/ddt.2018.01036 · doi-reference
10.1017/s0007114516001045
10.1017/s0007114516001045 · doi-reference
10.3748/wjg.v21.i29.8787
10.3748/wjg.v21.i29.8787 · doi-reference
Gut Microbiota, Host Organism, and Diet Trialogue in Diabetes and Obesity
10.3389/fnut.2019.00021 · doi-reference
Metabolomic and lipidomic assessment of the metabolic syndrome in Dutch middle-aged individuals reveals novel biological signatures separating health and disease
10.1007/s11306-019-1484-7 · doi-reference
Recent Progress in Metabolic Syndrome Research and Therapeutics
10.3390/ijms22136862 · doi-reference
Reduction of alpha-ketobutyrate by human serum
10.1038/1881110a0 · doi-reference
10.1371/journal.pone.0010883
10.1371/journal.pone.0010883 · doi-reference
Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance
10.2337/db12-0707 · doi-reference
Non-targeted metabolomics combined with genetic analyses identifies bile acid synthesis and phospholipid metabolism as being associated with incident type 2 diabetes
10.1007/s00125-016-4041-1 · doi-reference
1,5-Anhydroglucitol in diabetes mellitus
10.1007/s12020-012-9760-6 · doi-reference
10.1016/j.cell.2018.09.055
10.1016/j.cell.2018.09.055 · doi-reference
10.1016/j.cmet.2018.07.001
10.1016/j.cmet.2018.07.001 · doi-reference
10.1038/s41575-019-0258-z
10.1038/s41575-019-0258-z · doi-reference
10.1111/obr.12843
10.1111/obr.12843 · doi-reference
Association between microbiota-dependent metabolite trimethylamine-N-oxide and type 2 diabetes
10.3945/ajcn.117.157107 · doi-reference
Gut microbiota-derived metabolite trimethylamine N-oxide (TMAO) potentially increases the risk of obesity in adults: An exploratory systematic review and dose-response meta- analysis
10.1111/obr.12993 · doi-reference
Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome
10.3389/fphar.2018.01382 · doi-reference
10.1038/sj.emboj.7601049
10.1038/sj.emboj.7601049 · doi-reference
10.21037/tgh.2018.07.06
10.21037/tgh.2018.07.06 · doi-reference